|Company Name||Last Price||%
|Dr Reddys Labs||2726.25||-3.59||2939.80||1786.50||46,375.93|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|Scheme||No. of Shares|
|Reliance Equity Opportunities Fund - Retail Plan (G)||608,963|
|Reliance Pharma Fund (G)||241,343|
|Reliance Vision Fund - Retail Plan (G)||219,440|
|Reliance Tax Saver (ELSS) Fund (G)||219,236|
Sanofi India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 6,221.95 crore.The company has reported a standalone sales of Rs 461.10 crore and a Net Profit of Rs 92.7 crore for the quarter ended Dec 2013.
The company management includes Vijay Mallya - Chairman, Shailesh Ayyangar - Managing Director, F Briens - Director, Virginie Boucinha - Director, J M Georges - Director, S R Gupte - Director, A K R Nedungadi - Director, A Ortoli - Director, M G Rao - Alternate Director, Joanna Potts - Alternate Director, Rangaswamy R Iyer - Independent Director.
It is listed on the BSE with a BSE Code of 500674 and the NSE with an NSE Code of SANOFI.
Its Registered office is at Aventis House, 54/A, Sir Mathuradas Vasanji Road,,Andheri (East) Mumbai,Maharashtra - 400093.
Their Registrars are Link Intime India Pvt. Ltd.